NLS Pharmaceutics Ltd. Ordinary Shares
N/A
USD
N/A
N/A
...
Chart
Financials
Description
NLSP Company Description
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
NLSP Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NLSP Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of NLSP by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NLSP's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of NLSP in WallStreetBets Daily Discussion
NLSP News
Recent insights relating to NLSP
CNBC Recommendations
Recent picks made for NLSP stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NLSP
Corporate Flights
Flights by private jets registered to NLSP
Our Analysis